Refine by
Human Cancer Suppliers & Manufacturers
46 companies found
Premium
based inDueren, GERMANY
Since 2005, NIPPON Genetics EUROPE has stood for innovation and quality in biotechnology. In these two decades, we have evolved from a supplier of high quality Japanese technologies to a developer of our own groundbreaking solutions. Our products ...
Enables long term cell storage at -80°C or -196°C. Perfectly suited for hybridoma cells and HTP-applications. Bambanker Direct can be directly added to the cells – No washing and no centrifugation necessary. Improved cell recovery and ...
based inRedwood City, CALIFORNIA (USA)
Guardant Health is a leading precision oncology company dedicated to helping conquer cancer through our proprietary blood tests, vast data sets, and advanced analytics. We’re developing blood tests for early detection in high-risk populations and ...
based inShirley, NEW YORK (USA)
Profacgen is a state-of-the-art protein service provider located in Long Island, NY, USA. We provide custom protein services in the biological sciences, enabling access to the latest tools, techniques, and expertise with competitive pricing and ...
based inHamburg, GERMANY
Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. ...
based inSaint Louis, MISSOURI (USA)
Sequoia Vaccines is a clinical stage pharmaceutical company discovering and developing new vaccines preventing bacterial infections and medicines treating cancers and bacterial infections. Sequoia’s lead clinical candidate is a vaccine for the ...
Sequoia is developing an anticancer compound (SQ1274) for use against solid tumors including ovarian and lung ...
based inWellesley Hills, MASSACHUSETTS (USA)
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 50 countries, TargetMol has evolved into one of ...
based inSan Diego, CALIFORNIA (USA)
At Bionano Genomic, we are committed to unlocking understanding of genome biology to advance the promise of genomics in areas including cancer and human disease, agricultural bioengineering and genome discovery. Our team is not afraid to venture ...
based inShirley, NEW YORK (USA)
Creative Bioarray is a leading customer-centered biotechnology company and a pioneer with the latest technology of cell patterning. Creative Bioarray has an experienced expert team and is committed to providing comprehensive services and customized ...
Human (Parental) Brain Cancer Stem Cell (Plated cells are also available). 120 Population doublings or up to 12 passages. One million viable cells upon thawing of frozen cells, frozen vial of cells shipped in ...
based inHackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
Cell Line Select® is Champions' online, searchable database containing over 100 Human cancer cell lines, including characterization datasets such as gene mutations identified through Whole Exome Sequencing (WES) ...
based inHamburg, GERMANY
Indivumed GmbH was founded in 2002 by leading scientists with a drive to revolutionize cancer treatment through individualized therapy. As a physician-led, integrated global oncology company our experts leverage the world’s premier multi-omics ...
based inBurnaby, BRITISH COLUMBIA (CANADA)
Fusion Genomics is a Vancouver-based company that is advancing molecular diagnostics by developing identification tests for pathogens using proprietary technologies in combination with Next Generation Sequencing. Our ONETest products, in combination ...
based inNotting Hill, AUSTRALIA
Cartherics is developing its novel “off-the-shelf” (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human ...
This technology arms the patient’s own T cells with CARs, which enable them to “seek and destroy” cancer ...
based inOxford, UNITED KINGDOM
Scancell is a clinical stage biopharmaceutical company that is leveraging its proprietary research, built up over many years of studying the human adaptive immune system, to generate truly novel medicines to treat significant unmet needs in cancer ...
The Modi-2 vaccine exploits a second post-translational modification, stimulating the production of CD4 T cells using tumour-associated peptide epitopes in which the lysine residues are converted to homocitrulline. This change occurs via a process ...
based inBensheim, GERMANY
We specialise in the development and production of innovative parameters and detection methods for laboratory diagnostics and medical research. Our focus is the development of immunological detection methods for unoccupied niches. The products from ...
Bone Sialoprotein (BSP) is a glycoprotein, which accounts for approximately 10% of the non-collagenous matrix protein of bones. BSP (as well as other glycoproteins such as osteonectin and osteopontin) plays a regulatory role in bone metabolism, e.g. ...
based inOxford, UNITED KINGDOM
Physiomics are a leading oncology consultancy using proprietary state of the art Virtual TumourTM technology and other tools to predict and better understand the effects of cancer treatments. We work with partners developing cancer drugs to help ...
Virtual Tumour™ is our advanced, predictive modelling simulation tool used worldwide by global pharmaceuticals to small biotech companies to support oncology ...
based inGolden, COLORADO (USA)
At Vitro Biopharma, our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market, and ultimately, to address well-established multi-billion-dollar ...
Human Ovarian Serous Cancer Associated Fibroblasts. Cryopreserved at a low passage. High passage capabilities. Expands in VitroPlusIII Low Serum, Complete Medium (Vitro Biopharma, Cat. No. PC00B1–optimized for ...
based inWuhan, CHINA
Wuhan Healthcare Biotechnology Co., Ltd. (Healthcare) is specialized in the production of high quality in vitro diagnostic reagents and instrumentation products that empower clinicians to treat patients faster than before and intended for hospitals, ...
Translocations in bands 11q23.3-11q24 are associated with several human cancers, including acute lymphoid and acute myeloid leukemias (AML) and Ewing's sarcoma. ...
based inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
DEP® radiotheranostic conjugates have the potential to minimise off-target toxicity, optimise pharmacokinetics and enhance efficacy when used alone or in combination with other therapeutic approaches. The versatility of Starpharma’s ...
based inSanta Clara, CALIFORNIA (USA)
For more than 40 years, Agilent Technologies has been the leading provider of solutions for the detection, identification, and characterization of chemical and biological compounds. From environmental testing to semiconductor manufacturing, ...
The Cas9 endonuclease kit is part of an integrated solution for in-vitro CRISPR/Cas resesarch. Use this kit for in-vitro cloning of large genes or DNA fragments without the limitations imposed by common restriction enzymes or PCR fidelity. Allows ...
based inAmherst, NEW HAMPSHIRE (USA)
BUHLMANN Diagnostics Corp (BDC), Amherst NH is the North American affiliate of BÜHLMANN Laboratories AG, a leading worldwide operative manufacturer of ELISA kits, RIA kits, lateral flow assay kits, flow cytometry assay kits and turbidimetric assays ...
Flow CAST® Support in Drug Development: Inhibition of Basophil Activation is a Surrogate Biomarker for the Activity of Kinase ...